Addressing the Human Crisis in Modern Medicine

The healthcare sector is currently facing a human resources crisis of unprecedented scale, where the implementation of healthcare workforce technology supporting care teams has become a moral and operational imperative. For years, clinicians have been overburdened by manual administrative tasks, fragmented communication, and rigid scheduling practices that lead to chronic fatigue and a loss of professional autonomy. This pervasive burnout not only threatens the mental health of individual practitioners but also directly impacts patient safety and the overall quality of care. A clinical team that is exhausted and disconnected is far more likely to make errors and less able to provide the emotional presence that is essential for a positive patient experience.

The transition toward modern healthcare workforce management begins with a fundamental recognition that the clinician is the hospital’s most valuable asset. Digital tools are now being used to strip away the “administrative friction” that clogs the daily routine of doctors and nurses. By automating the more mundane aspects of hospital operations such as shift bidding, leave management, and credential tracking these systems return valuable time to the care team. This time can then be reinvested in direct patient interaction, leading to higher levels of clinical excellence and professional fulfillment. When the technology works to serve the human staff, the entire institution benefits from a more engaged, resilient, and effective workforce.

The Power of Predictive Workforce Analytics

One of the most transformative aspects of modern hospital staffing technology is the move from reactive to proactive resource management. Workforce analytics healthcare platforms leverage the power of big data to predict future staffing needs with remarkable accuracy. By analyzing variables such as historical patient census data, local public health trends, and even the complexity of the current patient population, these systems can forecast the required clinical capacity several weeks in advance. This allows administrators to adjust staffing levels in a way that ensures every unit is adequately supported without the need for last-minute, high-stress call-outs or the use of expensive agency staff. This predictive capability is a cornerstone of healthcare workforce technology supporting care teams, as it provides a stable and predictable environment for everyone.

Furthermore, these analytics platforms provide deep insights into the well-being of the staff themselves. They can track patterns that correlate with burnout, such as high rates of overtime, frequent shift changes, or a high volume of missed breaks. By identifying these “red flags” early, hospital leadership can intervene with targeted support, whether through adjusting the workload, offering additional resources, or simply providing a much-needed break. This data-driven approach to staff welfare ensures that the institution is as focused on the health of its employees as it is on the health of its patients. In the long run, this proactive care for the clinician is the best way to ensure the long-term sustainability of the medical profession and the safety of the community it serves.

Digital Scheduling and the Rise of Professional Autonomy

A significant driver of professional dissatisfaction in healthcare has historically been the lack of control that clinicians have over their own schedules. Modern digital workforce solutions are changing this by introducing self-service scheduling platforms that prioritize flexibility and autonomy. Through mobile-first applications, staff members can view their schedules, request changes, and pick up additional shifts from anywhere, at any time. These platforms use intelligent algorithms to ensure that every shift is covered by the appropriate mix of skills and experience, while also honoring the personal preferences and work-life balance of the individual. This shift toward a more collaborative and transparent scheduling process is a vital part of healthcare workforce technology supporting care teams.

When clinicians have a voice in when and where they work, they feel more respected and valued by their employer. This increased sense of agency leads to higher levels of job satisfaction and a significant reduction in turnover rates. Furthermore, these platforms can be used to manage “flexible pools” of staff who are willing to work across different departments or locations as needed. This fluidity allows the hospital to be more responsive to sudden changes in patient demand without placing an undue burden on any single team. By utilizing the power of digital connectivity to create a more agile and human-centered scheduling system, healthcare organizations are building a workforce that is ready for the challenges of the 21st century.

Digital Training and Continuous Professional Growth

In the rapidly evolving world of medicine, continuous learning is not just a requirement; it is a necessity for clinical excellence. However, the time required for traditional training can be difficult to find in an already overextended schedule. Modern healthcare workforce technology supporting care teams addresses this by providing on-demand, digital training platforms that deliver bite-sized educational content directly to the clinician’s device. These modules can be completed during quiet moments in a shift or even from home, allowing for a more flexible and personalized approach to professional development. This accessibility ensures that the entire team is always up to date with the latest evidence-based practices and regulatory requirements.

Beyond compliance, these platforms also offer opportunities for career advancement and specialized certification. By tracking the skills and interests of every staff member, the system can suggest training paths that align with their personal professional goals. This commitment to the long-term growth of the individual is a powerful tool for retention and ensures that the institution is constantly building a deeper and more capable talent pool. When a healthcare organization invests in the intellectual and professional development of its staff, it sends a clear signal that it is committed to their long-term success. This culture of learning is essential for maintaining the high standards of care that patients expect and deserve.

Communication, Collaboration and Productivity Tools

Effective communication is the lifeblood of any high-performing care team, yet fragmented and outdated communication methods continue to be a source of frustration and delay in many hospitals. Staff productivity tools are now being used to bridge these gaps, providing a unified and secure platform for real-time collaboration. These tools integrate secure messaging, clinical alerts, and patient data into a single interface, allowing for seamless communication between different departments and specialties. When a nurse can instantly securely message a physician with a clinical concern, or a physical therapist can view the latest surgical notes on their own device, the entire care process becomes more efficient and safer for the patient.

Furthermore, these tools can be used to automate many of the routine communication tasks that currently consume a significant portion of a clinician’s time. For example, the system can automatically send alerts to the appropriate team members when a lab result is ready or when a patient’s vital signs fall outside of a specific range. This “closed-loop” communication ensures that nothing falls through the cracks and that every member of the team has the information they need to provide the best possible care. By reducing the noise and clutter of traditional communication, healthcare workforce technology supporting care teams allows clinicians to focus their attention where it matters most: on the person in the bed. The result is a more calm, organized, and focused clinical environment that is conducive to both healing and professional excellence.

The Impact on Patient Outcomes and Clinical Safety

While the immediate goal of workforce technology is to support the staff, the ultimate beneficiary is always the patient. A well-supported, properly staffed, and highly informed clinical team is far more capable of delivering the high-quality care that leads to positive outcomes. By utilizing digital workforce solutions to optimize staffing levels and reduce burnout, hospitals are directly improving the safety of their patients. The data is clear: institutions with high levels of staff engagement and adequate staffing ratios have lower rates of medical errors, fewer patient falls, and better patient satisfaction scores. The health of the workforce is the single most important predictor of the health of the institution.

Furthermore, the use of workforce technology allows for a more personalized and patient-centered approach to care. When scheduling systems ensure that the right mix of expertise is available on every shift, the hospital can offer more comprehensive and multidisciplinary care for patients with complex needs. This coordinated approach ensures that every aspect of the patient’s health is addressed by a specialist who is well-rested and fully informed. By treating the clinical workforce as a vital and integrated part of the patient care journey, healthcare organizations are ensuring that they can provide the highest standard of medicine for every person who walks through their doors. This is the true power of healthcare workforce technology supporting care teams: it creates a foundation of stability and excellence that supports everything else the hospital does.

Conclusion: The Resilient Future of the Medical Workforce

The ongoing journey of healthcare workforce technology supporting care teams is an investment in the future of medicine itself. We are moving toward a more humanized and sustainable model of healthcare management, where technology acts as a supportive partner rather than an administrative burden. By prioritizing the well-being and professional growth of our clinicians, we are ensuring that the medical profession remains a vibrant and rewarding calling for the next generation. The challenges of the future are significant, but with the right tools and a commitment to our people, we are more than capable of meeting them.

In the end, the success of any healthcare system is measured by the lives it heals and the comfort it provides. This work is only possible through the dedication and skill of the human beings who make up the care team. By building a digital infrastructure that protects, empowers, and supports these individuals, we are ensuring that they have the resources they need to continue their vital mission. This is the promise of modern healthcare workforce management: a future where the clinician is respected, the team is supported, and every patient receives the best possible care from a team that is ready and able to provide it. This is a future we are building one digital tool and one supported shift at a time.

The Omnypulse platform includes the Omnypulse catheter and Trupulse generator, integrating with the Carto 3 mapping system to combine pulsed field ablation therapy and advanced cardiac mapping. Results from the OMNY-AF study, presented at the 31st Annual AF Symposium in Boston, covered a 30-patient pilot cohort across eight centres.

The findings showed 100% acute procedural success with no procedure-associated adverse events. More than half of cases were completed with zero fluoroscopy, and 90% of patients met the primary effectiveness endpoint at 12 months.

“The 12-month data provide encouraging early evidence on the OMNY-AF study with promising safety outcomes – no procedure-related adverse events or MRI-detected cerebral lesions – across eight centers in the pilot phase. In my cases during the ongoing OMNY-AF trial, the seamless integration of advanced mapping, ultrasound, and PF Index with contact force were valuable for precise and efficient pulsed field energy delivery,” said Dr. Dinesh Sharma, section head of cardiac electrophysiology at the Naples Heart Institute and the study’s presenting author.

Alongside Johnson & Johnson MedTech Omnypulse results, the company shared new safety data for its Varipulse pulsed field ablation platform. A study presented at the same meeting assessed neurovascular event rates following workflow enhancements and the introduction of an optimized irrigation flow rate.

Varipulse reported a 0.22% rate of neurovascular events among 6,811 patients after implementation of these updates. Further supporting data consisted of a physician questionnaire detailing 850 procedures which found low complication rates and no instances of coronary spasm or death. REAL AF registry also demonstrated low overall acute safety event rate with zero neurovascular events.

“These data reinforce confidence in the consistency of safety outcomes observed across Johnson & Johnson’s electrophysiology portfolio. As a relatively new energy modality, pulse field ablation technologies should be individually evaluated for safety and reproducibility in atrial fibrillation ablation,” said Dr. Gregory Michaud, chief medical and scientific officer, Electrophysiology, Johnson & Johnson MedTech. “As pulsed field ablation continues to evolve, rigorous evidence generation and transparent data sharing will be essential to advancing the science and enabling the next wave of innovation with this technology.”

The nurse staffing rule repeal removes federally defined staffing thresholds that operators argued were financially unsustainable and operationally unworkable amid prolonged labor shortages. The decision carries direct implications for facility budgets, workforce planning, compliance strategies and the continuity of care delivery, particularly in rural markets where hiring challenges remain acute.

The Department of Health & Human Services (HHS) confirmed earlier this week that it has revoked the staffing standards originally designed to set minimum coverage levels for registered nurses and nursing assistants in nursing homes and long-term care facilities. Operators had maintained that such requirements imposed disproportional cost pressures and could not be met in a constrained labor environment.

According to HHS, rural providers would have faced the greatest burden under the rule, which the agency acknowledged positioned many facilities at risk of noncompliance or reduced service availability. Health systems and facility operators had consistently pushed back on the regulation, noting that mandatory staffing ratios could force reductions in operational capacity or lead to facility closures if workforce supply remained insufficient.

The provisions set aside under the repeal would have required a registered nurse on-site 24 hours a day, along with an average of 0.55 hours of daily registered nurse care and 2.45 hours of daily nurse aide care per resident. These thresholds were intended to strengthen care protections but were criticized by operators as unattainable given national workforce constraints.

Industry groups representing nursing homes and long-term care facilities, including the American Health Care Association and the National Center for Assisted Living, had campaigned extensively against the rule. They described the standards as unrealistic and argued that facilities would be unable to maintain operations without substantial increases in staffing supply or government subsidies.

Health & Human Services Secretary Robert F. Kennedy Jr. stated, “Rigid, one-size-fits-all mandates fail patients.”
“This Administration will safeguard access to care by removing federal barriers—not by imposing requirements that limit patient choice,” he said in a statement.

Charlene MacDonald, executive vice president of public affairs for the Federation of American Hospitals, supported the decision. “This repeal rightfully reflects the reality that long-term care facilities are facing challenging workforce shortages,” MacDonald said in a statement. “Rolling back this regulatory burden recognizes flexible staffing coupled with innovation improves the quality of care, reduces staff burnout, and keeps facilities’ doors open so patients can access the care they need when they need it.”

Stacey Hughes, executive vice president of government relations and public policy for the American Hospital Association, echoed concerns about operational feasibility. “The AHA has repeatedly raised concerns that the requirements could exacerbate workforce shortages, lead to facility closures and jeopardize access to care, especially in rural and underserved communities that often do not have the workforce levels to support these requirements,” Hughes said in a statement.

The American Health Care Association earlier stated that the Biden-era regulation represented “an unreasonable standard” that “creates an impossible task for providers” during a nationwide workforce shortage.

Advocacy groups for seniors sharply criticized the nurse staffing rule repeal decision, noting that the staffing standards, considered by some the most significant care protections in decades, were estimated to save thousands of lives annually. The National Consumer Voice for Quality Long-Term Care said it “strongly condemns” the rollback, arguing the rule would have materially improved resident safety. The AARP, which had previously opposed proposals to delay implementation to 2035, reiterated that the standards were “long-overdue.”

With the federal standards rescinded, nursing home and long-term care operators will revert to state-defined staffing frameworks while advocacy groups continue pressing for federally enforced protections.

Researchers have gone ahead and created a system named CytoDiffusion, which makes use of generative AI, which is the same kind of technology behind the image generators like DALL-E, in order to study the shape as well as the structure of blood cells.

Unlike the numerous other AI models, which are trained to simply recognize the patterns, CytoDiffusion, which is developed by the researchers at the University of Cambridge, University College London as well as Queen Mary University of London, could precisely pinpoint a wide range of normal blood cell appearances and also spot unusual or rare cells, which may indicate the disease. The results are indicated in the Nature Machine Intelligence journal.

Apparently, the spotting of subtle differences within the blood cell size and shape as well as the appearance is indeed a cornerstone when it comes to diagnosing numerous blood disorders. However, the task needs to have years of training, and even then, there would be varied doctors who can disagree on challenging cases. According to the study’s first author from the Department of Applied Mathematics and Theoretical Physics in Cambridge, Simon Deltadahl, all got numerous different kinds of blood cells, which have varied properties as well as different roles within the body. There are white blood cells that specialize in fighting the infection, for instance. Knowing what an unusual or diseased blood cell would look like under a microscope is indeed an important part of diagnosing numerous diseases.

But a typical blood smear goes on to have thousands of cells, which are far more than any human could evaluate. Deltadahl adds that humans cannot have a look at all the cells in a smear, as it is just not possible. Their model can go ahead and automate that process, highlight anything that looks unusual for human review, and triage the routine cases.

As per co-senior author from Queen Mary University of London, Dr. Suthesh Sivapalaratnam, the clinical challenge he went on to face as a junior hematology doctor was that after a day of work, he would have a lot of blood films to evaluate. As he was evaluating them in the late hours, he became convinced that AI would surely do a much better job than himself.

In order to develop CytoDiffusion, the researchers went on to train the system on more than half a million images of blood smears that were collected at Addenbrooke’s Hospital located in Cambridge. The dataset, which is the largest of its kind, had both common blood cell types as well as rarer examples and also elements that can confuse the automated systems. Through modelling the complete distribution of cell appearances and not just learning to separate the categories, the AI became much more robust to differences between the hospitals, microscopes, and staining methods, and also better able to gauge the rare or abnormal blood cells.

In tests, CytoDiffusion could as well detect abnormal blood cells, which are linked to leukemia, with far more sensitivity as compared to the existing systems. It also matched or even at times surpassed the present state-of-the-art models, even when given far fewer training examples, and also quantified its own uncertainty. Deltadahl added that when they tested its precision, the system was slightly better as compared to humans; however, where it actually stood out was in knowing when it was not sure. Their model would never say that it was certain and then be wrong; however, that is something that the humans sometimes do.

Professor Michael Roberts, the co-senior author, also from the Department of Applied Mathematics and Theoretical Physics of Cambridge, said that they assessed the method against many of the issues that were seen in machines and also the degree of uncertainty within the labels. This framework goes on to give a multi-faceted view of the model performance that they believe is indeed going to be beneficial to the researchers.

In addition to this, the team also showed that CytoDiffusion could also generate synthetic blood cell images that are indistinguishable from real ones. In one of the Turing tests with ten experienced hematologists, human experts were indeed no better than having a chance at telling the real from the AI-generated images. Deltadahl recalled that really surprised him. These are people who go on to stare at blood cells all times of the day, and even they could not tell.

As part of the project, the researchers are also releasing what, according to them, is the largest publicly available dataset pertaining to peripheral blood smear images in the world, which is more than half a million overall. Through making this resource open, they also hope to empower the researchers across the world so as to build as well as test new AI models, democratize the access when it comes to high-quality medical data, and, at the end of the day, contribute to much better patient care.

While the results really look quite promising, the researchers go on to say that CytoDiffusion isn’t a replacement for the trained clinicians. Rather, it is designed in order to support them by accelerating the flagging of abnormal cases for review and also handling many more routine ones in an automated form. UCL’s Professor Parashkev Nachev, who is the co-senior author, says that the true value of healthcare AI lies not just in approximating the human expertise at a lower cost, but rather in enabling greater diagnostic, prescriptive, and prognostic power than what either the experts or simple statistical models can attain.  Their work suggests that generative AI is indeed going to be central to this mission, transforming not just the fidelity when it comes to clinical support systems but also their insight into limits pertaining to their own knowledge.

This kind of metacognitive awareness, knowing what one does not know, is crucial to clinical decision-making, and there are machines that may be better at it as opposed to what humans are.

According to the researchers, further work is required so as to make the system much faster and to also test it throughout the diverse patient populations in order to make sure of fairness as well as precision.

Notably, the research was supported in part by Wellcome, the British Heart Foundation, the Trinity Challenge, the NHS Foundation Trust of the Cambridge University Hospitals, Barts Health NHS Trust, the NIHR UCLH Biomedical Research Centre, the NIHR Cambridge Biomedical Research Centre, and the NHS Blood and Transplant. The research was conducted through the imaging working group of the BloodCounts! consortium, which looks forward to using AI in order to improve the blood diagnostics across the world.

“These updated results align with previous findings and further demonstrate that CCH is both effective and well tolerated in men with Peyronie’s disease and ventral curvature,” said Peter Bajic, MD, Associate Professor of Urology and Director of Men’s Health at Cleveland Clinic’s Glickman Urological Institute and presenting author of the presentation. “This consistency is encouraging for both clinicians and patients seeking nonsurgical treatment options.”

The Endo-sponsored presentation is below:

• Collagenase Clostridium Histolyticum (CCH) for Ventral Curvature (VC) of the Penis Due to Peyronie’s Disease (PD): Updated Results From a Noninterventional, Retrospective, Multicenter Study
• Authors: Matthew J. Ziegelmann, MD; Billy H. Cordon, MD; Majdee M. Islam, MD; Alexander J. Tatem, MD; Richard C. Bennett, MD; Faysal A. Yafi, MD, FRCSC; Petar Bajic, MD; Nelson E. Bennett, Jr., MD; Helen L. Bernie, DO, MPH; Marcelo Mass-Lindenbaum, MD; Muhammed A. M. Hammad, MBBCh, MS; Kristen Gumpf, PA-C; James Tursi, MD; David Hurley, MD; Jeffrey Andrews, MS; Tina Rezakhani, PharmD, MBA; Marian Ayad, PharmD, BCPS; Mohit Khera, MD, MBA, MPH; Bruce R. Kava, MD; Jesse N. Mills, MD

About the Study

This Phase 4 multicenter, noninterventional, retrospective study evaluated the effectiveness and safety of CCH in adult men with PD and ventral curvature (VC). Researchers reviewed medical charts of patients aged 18 and older diagnosed with VC and a palpable plaque, treated with CCH between 2014 and each site’s study start date.

The primary endpoint was percent change in penile VC, while secondary endpoints included mean degree change in penile VC and the proportion of patients achieving at least 30% improvement in penile VC from baseline to last visit.

No serious or severe treatment-related adverse events were reported, and there were no cases of urethral involvement or injury.

These updated findings reinforce that CCH is effective and well tolerated in men with PD and VC, supporting its continued use as a nonsurgical treatment option for this population.

About Peyronie’s Disease

Peyronie’s disease (PD) is a condition in which a buildup of fibrous scar tissue causes a curvature deformity of the penis. This curvature can be bothersome during arousal and intimacy.1 It is estimated that PD can affect as many as 1 in 10 men in the U.S.,2 but diagnosis rates remain low because men with PD may be too uncomfortable to speak up and get help.3

XIAFLEX® INDICATION

XIAFLEX® is indicated for the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

IMPORTANT SAFETY INFORMATION

Do not receive XIAFLEX if:

• the Peyronie’s plaque to be treated involves the “tube” that your urine passes through (urethra).
• you are allergic to collagenase clostridium histolyticum or any of the ingredients in XIAFLEX, or to any other collagenase product. See the end of the Medication Guide for a complete list of ingredients in XIAFLEX.

XIAFLEX can cause serious side effects, including:

1.  Penile fracture (corporal rupture) or other serious injury to the penis. Receiving an injection of XIAFLEX may cause damage to the tubes in your penis called the corpora. After treatment with XIAFLEX, one of these tubes may break during an erection. This is called a corporal rupture or penile fracture. This could require surgery to fix the damaged area. Damage to your penis might not get better after a corporal rupture.

• After treatment with XIAFLEX, blood vessels in your penis may also break, causing blood to collect under the skin (hematoma). This could require a procedure to drain the blood from under the skin. If a hematoma appears, skin and soft tissue necrosis (death of skin cells) may develop in that area, which could require surgery.

Symptoms of corporal rupture or other serious injury to your penis may include:

• a popping sound or sensation in an erect penis
• sudden loss of the ability to maintain an erection
• pain in your penis
• purple bruising and swelling of your penis
• difficulty urinating or blood in the urine

Call your healthcare provider right away if you have any of the symptoms of corporal rupture or serious injury to the penis listed above.

Do not have sex or any other sexual activity between the first and second injections of a treatment cycle.

Do not have sex or have any other sexual activity for at least 4 weeks after the second injection of a treatment cycle with XIAFLEX and after any pain and swelling has gone away.

XIAFLEX for the treatment of Peyronie’s disease is only available through a restricted program called the XIAFLEX Risk Evaluation and Mitigation Strategy (REMS) Program.

2. Hypersensitivity reactions, including anaphylaxis. Severe allergic reactions can happen in people who receive XIAFLEX, because it contains foreign proteins.

Call your healthcare provider right away if you have any of these symptoms of an allergic reaction after an injection of XIAFLEX:

• hives
• swollen face
• breathing trouble
• chest pain
• low blood pressure
• dizziness or fainting

3. Back pain reactions. After receiving an injection of XIAFLEX for Peyronie’s disease, you may suddenly feel back pain, including severe lower back pain moving to your legs, feet, chest and arms. The back pain may also include spasms and make it hard to walk. These symptoms usually go away in 15 minutes or less, but may last longer.

Tell your healthcare provider right away if you have sudden back pain, chest pain, or hard time walking after an injection.

4. Fainting. Fainting (passing out) or near fainting can happen in men who receive XIAFLEX, especially if they have severe penile pain.

If you have dizziness or feel faint after receiving XIAFLEX, lie down until the symptoms go away.

Before receiving XIAFLEX, tell your healthcare provider if you have had an allergic reaction to a previous XIAFLEX injection, have a bleeding problem, received XIAFLEX for another condition, or any other medical conditions. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using XIAFLEX with certain other medicines can cause serious side effects. Especially tell your healthcare provider if you take medicines to thin your blood (anticoagulants). If you are told to stop taking a blood thinner before your XIAFLEX injection, your healthcare provider should tell you when to restart the blood thinner. Ask your healthcare provider or pharmacist for a list of these medicines, if you are not sure.

What should I avoid while receiving XIAFLEX?

Avoid situations that may cause you to strain your stomach (abdominal) muscles, such as straining during bowel movements.

Do not use a vacuum erection device during your treatment with XIAFLEX.

XIAFLEX can cause serious side effects, including increased chance of bleeding. Bleeding or bruising at the injection site can happen in people who receive XIAFLEX. Talk to your healthcare provider if you have a problem with your blood clotting. XIAFLEX may not be right for you.

The most common side effects with XIAFLEX for the treatment of Peyronie’s disease include:

• a small collection of blood under the skin at the injection site (hematoma)
• swelling at the injection site or along your penis
• pain or tenderness at the injection site, along your penis and above your penis
• penis bruising
• itching of your penis or scrotum (genitals)
• painful erection
• erection problems (erectile dysfunction)
• changes in the color of the skin of your penis
• blisters at the injection site
• pain with sex
• a lump at the injection site (nodule)

Tell your healthcare provider if you have any side effect that bothers you or does not go away.

These are not all of the possible side effects with XIAFLEX. For more information, ask your healthcare provider or pharmacist. You may report side effects to FDA at 1-800-FDA-1088.

WHAT IS XIAFLEX?

XIAFLEX is a prescription medicine used to treat adult men with Peyronie’s disease who have a “plaque” that can be felt and a curve in their penis greater than 30 degrees when treatment is started.

It is not known if XIAFLEX is safe and effective in children under the age of 18.

According to the researchers involved, the use of telemedicine apps in the surveillance and treatment of high-risk pregnancies has risen dramatically in prenatal health services as a result of the COVID-19 pandemic. A strong evidence-based assessment of the usefulness of telehealth arose as a result of all this, the researchers added and that and this constituted the framework for the development of the latest research.

WHY DOES IT MATTER?

According to the researchers, roughly 22% of pregnancies are classified as high-risk due to long-term health concerns, infections, past pregnancy difficulties, and perhaps other factors. The researchers are of the opinion that the care of an elevated pregnancy may require a tailored and inventive strategy, and one of these cutting-edge methods is telehealth, which has grown significantly in recent years.

Over the last five years, the research team looked at papers involving telemedicine and high-risk pregnancies from throughout the world. Mobile apps, a web-based platform, and phone conversations were among the interventions. They discovered that telehealth treatments improved maternal and neonatal health and reduced costs. The findings are important because they show that current technologies may be utilised to control high-risk pregnancies.

The telehealth strategy reduced the overall number of face-to-face and ultrasonography visits while raising the quantity of phone nursing follow-ups and overall nurse interventions. Non-stress appointments and those seeking emergency obstetric care were not affected.

Through use of antenatal corticosteroids as well as hypoglycemic medication at delivery, conformance with actual blood glucose measurements, and induction intervention at delivery were all less in the telehealth cohort, but the use of antenatal corticosteroids and hypoglycemic medication at delivery, compliance with actual blood glucose measurement techniques, and induction intervention during delivery were all significantly higher. The rates of maternal mortality were also higher. Since this conclusion is based on the findings of just one study in the analysis, the study team concluded, it is evident that far more research is essential. The same may be said about neonatal mortality.

Medical therapy, total gestational weight gain, pregnancy-related health problems, method and side effects of delivery, maternal intensive care admittance, fetal-neonatal development and growth, neonatal health issues and death, follow-ups, and care costs were all similar between the groups. The researchers noted that the results studied included multiple pregnancy risk classes, were collected from several telemedicine apps, and were handled from a broad view that covered mother, foetal, and financial effects, all contributing to its strengths and reinforcing the outcomes.

THE GROWING TREND

To solve the maternal health and mortality crisis in the United States, researchers and innovators have resorted to technology, such as remote health monitoring and other telemedicine services. Other experts have suggested that connectivity is a critical component of meeting maternity care needs.

In a December interview, Mayealie Adams, managing director of government and external affairs at Philips, said that with more data on the crossover between pregnancy outcomes and elevated internet access, they can effectively assign their broadband resources in such a manner that most efficaciously rewards communities that need them, especially in the area of maternal health.

IN THE BOOKS

The study authors said that the findings of this study, as well as international health organisation suggestions, demonstrate that healthcare practitioners and admins can use telecare as a secure method in the tracking and care of pregnancies at high risk, leading to the success of antepartum care services.

At the same time, it may be advised that randomised controlled trials on the impact of telehealth on various risk groups during pregnancy be done. This would lead to significant studies and meta-analysis that would provide greater evidence.